Filing Details

Accession Number:
0001415889-25-019067
Form Type:
4
Zero Holdings:
No
Publication Time:
2025-07-02 16:33:27
Reporting Period:
2025-06-30
Filing Date:
2025-07-02
Accepted Time:
2025-07-02 16:33:27
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
921299 Fibrogen Inc FGEN Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1420987 A James Schoeneck C/O Fibrogen, Inc.
350 Bay Street, Suite 100, #6009
San Francisco CA 94133
No No No No
Transaction Summary
Purchased: 23,567 shares Avg. Price: $5.07 Total Value: $119,484.69
Number of Shares After Transactions: 39,666 shares
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2025-06-30 23,567 $5.07 39,666 No 4 P Indirect By Trust
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect By Trust
Footnotes
  1. Price reported is a weighted-average purchase price. The shares were purchased at prices ranging from $4.935 to $5.25. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares purchased at each separate price.
  2. Reflects a 1-for-25 reverse stock split effective on June 16, 2025.